- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01151150
The Phenomenon of "Chronic Lyme"; an Observational Study
July 25, 2011 updated by: Sorlandet Hospital HF
The current study is set up to chart clinically and laboratory findings in Norwegian patients with symptoms attributed by themselves or their doctor to ongoing chronic Bb infection.
Objectives is to assess laboratory findings in relation to established diagnostic criteria and to form a picture of the burden of symptoms and illness perception in this group of patients.
The study is essentially exploratory, and is supposed to raise rather than to test hypotheses.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Anticipated)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kristiansand, Norway, 4633
- Sølandet Hospital HF
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients are eligible if they themselves or their physician suspected that they suffer from ongoing chronic Bb infection
Description
Inclusion Criteria:
- Symptoms attributed by themselves or their doctor to ongoing chronic Bb infection
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2010
Primary Completion (ACTUAL)
April 1, 2011
Study Completion (ACTUAL)
May 1, 2011
Study Registration Dates
First Submitted
June 24, 2010
First Submitted That Met QC Criteria
June 24, 2010
First Posted (ESTIMATE)
June 25, 2010
Study Record Updates
Last Update Posted (ESTIMATE)
July 26, 2011
Last Update Submitted That Met QC Criteria
July 25, 2011
Last Verified
June 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Chronic Lyme
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Lyme Borreliosis
-
Baxalta now part of ShireBaxter Innovations GmbHCompleted
-
PfizerValneva Austria GmbHCompletedLyme Borreliosis, Nervous SystemBelgium, United States
-
Centre Hospitalier Universitaire de Saint EtienneRecruitingPhysical Activity | Lyme Borreliosis | Lyme Borreliosis, Nervous SystemFrance
-
PfizerValneva Austria GmbHActive, not recruitingLyme BorreliosisUnited States
-
PfizerValneva Austria GmbHCompletedLyme BorreliosisUnited States
-
PfizerCompletedLyme BorreliosisUnited States, Germany, Belgium
-
Lyme Diagnostics Ltd.Pharmahungary GroupCompletedLyme BorreliosisAustria, Czechia, Germany, Hungary, Poland, Slovakia
-
University Hospital, Strasbourg, FranceRecruitingLyme BorreliosisFrance
-
University Medical Centre LjubljanaUnknown
-
University Hospital, Strasbourg, FranceSociété de Dermatologie FrançaiseActive, not recruiting